Really? Allergan CEO Brent Saunders, confessing his company participated in ghastly price increases in the past, says his company will limit price increases to single-digits.
According to an LA Times report, Allergan sells 30 capsules of its (ineffective) Namenda XR drug for about $440. An older generic version of Namenda (also ineffective) sells for $20. [LA TIMES Sept 8, 2016] The ineffectiveness is well documented. [Center4Research.org; Consumer Reports]